Alpha 2.0
Login Register
» Authors » N Kumarasamy

N Kumarasamy

Explore the profile of N Kumarasamy including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 143
Citations 2373
Followers 0
Related Specialties
Infectious Diseases
General Medicine
Ophthalmology
Top 10 Co-Authors
S Solomon
Suniti Solomon
Kenneth H Mayer
P Balakrishnan
Kartik K Venkatesh
S Poongulali
J Biswas
Timothy P Flanigan
S Pujari
R Ditangco
Published In
HIV Med
Indian J Ophthalmol
Int J STD AIDS
Clin Infect Dis
J Acquir Immune Defic Syndr
Affiliations
Soon will be listed here.
Recent Articles
1.
Blood absolute lymphocyte count and trajectory are important in understanding severe COVID-19
Paules C, Nordwall J, Shaw-Saliba K, Aberg J, Gardner E, Goodman A, et al.
BMC Infect Dis . 2025 Jan; 25(1):67. PMID: 39810077
Background: Low blood absolute lymphocyte count (ALC) may predict severe COVID-19 outcomes. Knowledge gaps remain regarding the relationship of ALC trajectory with clinical outcomes and factors associated with lymphopenia. Methods:...
2.
Service delivery challenges in HIV care during the first year of the COVID-19 pandemic: results from a site assessment survey across the global IeDEA consortium
Brazier E, Ajeh R, Maruri F, Musick B, Freeman A, Wester C, et al.
J Int AIDS Soc . 2022 Dec; 25(12):e26036. PMID: 36504431
Introduction: Interruptions in treatment pose risks for people with HIV (PWH) and threaten progress in ending the HIV epidemic; however, the COVID-19 pandemic's impact on HIV service delivery across diverse...
3.
Association of body mass index with immune recovery, virological failure and cardiovascular disease risk among people living with HIV
Han W, Jiamsakul A, Jantarapakde J, Yunihastuti E, Choi J, Ditangco R, et al.
HIV Med . 2020 Nov; 22(4):294-306. PMID: 33200864
Objectives: We conducted a longitudinal cohort analysis to evaluate the association of pre-treatment body mass index (BMI) with CD4 recovery, virological failure (VF) and cardiovascular risk disease (CVD) markers among...
4.
Virological failure and HIV drug resistance among adults living with HIV on second-line antiretroviral therapy in the Asia-Pacific
Ross J, Jiamsakul A, Kumarasamy N, Azwa I, Merati T, Do C, et al.
HIV Med . 2020 Nov; 22(3):201-211. PMID: 33151020
Objectives: To assess second-line antiretroviral therapy (ART) virological failure and HIV drug resistance-associated mutations (RAMs), in support of third-line regimen planning in Asia. Methods: Adults > 18 years of age...
5.
Ocular syphilis in patients with human immunodeficiency virus/acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy
Sudharshan S, Menia N, Selvamuthu P, Tyagi M, Kumarasamy N, Biswas J
Indian J Ophthalmol . 2020 Aug; 68(9):1887-1893. PMID: 32823409
Purpose: Re-emergent ocular syphilis in patients with Human immunodeficiency virus (HIV) co-infection has both diagnostic and management difficulties because of the overlapping risk factors. The clinical manifestations described in non-HIV...
6.
Atherosclerotic cardiovascular disease screening and management protocols among adult HIV clinics in Asia
Boettiger D, Law M, Ross J, Huy B, Heng B, Ditangco R, et al.
J Virus Erad . 2020 Mar; 6(1):11-18. PMID: 32175086
Objectives: Integration of HIV and non-communicable disease services improves the quality and efficiency of care in low- and middle-income countries (LMICs). We aimed to describe current practices for the screening...
7.
Early mortality after late initiation of antiretroviral therapy in the TREAT Asia HIV Observational Database (TAHOD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) Asia-Pacific
Rupasinghe D, Kiertiburanakul S, Kamarulzaman A, Zhang F, Kumarasamy N, Chaiwarith R, et al.
HIV Med . 2019 Dec; 21(6):397-402. PMID: 31852025
Objectives: Early mortality among those still initiating antiretroviral therapy (ART) with advanced stages of HIV infection in resource-limited settings remains high despite recommendations for universal HIV treatment. We investigated risk...
8.
Diabetes, mortality and glucose monitoring rates in the TREAT Asia HIV Observational Database Low Intensity Transfer (TAHOD-LITE) study
Bijker R, Kumarasamy N, Kiertiburanakul S, Pujari S, Sun L, Ng O, et al.
HIV Med . 2019 Jul; 20(9):615-623. PMID: 31338975
Objectives: Diabetes is a growing cause of morbidity and mortality in people living with HIV (PLHIV) receiving antiretroviral therapy (ART). We investigated the association between fasting plasma glucose (FPG) levels...
9.
Long-term loss to follow-up in the TREAT Asia HIV Observational Database (TAHOD)
Jiamsakul A, Kiertiburanakul S, Ng O, Chaiwarith R, Wong W, Ditangco R, et al.
HIV Med . 2019 Apr; 20(7):439-449. PMID: 30980495
Objectives: With earlier antiretroviral therapy (ART) initiation, time spent in HIV care is expected to increase. We aimed to investigate loss to follow-up (LTFU) in Asian patients who remained in...
10.
Cardiovascular disease-related mortality and factors associated with cardiovascular events in the TREAT Asia HIV Observational Database (TAHOD)
Bijker R, Jiamsakul A, Uy E, Kumarasamy N, Ditango R, Chaiwarith R, et al.
HIV Med . 2019 Jan; 20(3):183-191. PMID: 30620108
Objectives: With aging of the HIV-positive population, cardiovascular disease (CVD) increasingly contributes to morbidity and mortality. We investigated CVD-related and other causes of death (CODs) and factors associated with CVD...